Georgios Amanakis1, Junhui Sun1, Maria M Fergusson1, Shane McGinty1, Chengyu Liu2, Jeffery D Molkentin3, Elizabeth Murphy1. 1. Cardiovascular Branch, NHLBI, National Institutes of Health, Bethesda, MD, USA. 2. Transgenic Core Facility, NHLBI, National Institutes of Health, Bethesda, MD, USA. 3. Division of Molecular and Cardiovascular Biology, Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Abstract
AIMS: Cyclophilin-D is a well-known regulator of the mitochondrial permeability transition pore (PTP), the main effector of cardiac ischaemia/reperfusion injury. However, the binding of CypD to the PTP is poorly understood. Cysteine 202 (C202) of CypD is highly conserved among species and can undergo redox-sensitive post-translational modifications. We investigated whether C202 regulates the opening of PTP. METHODS AND RESULTS: We developed a knock-in mouse model using CRISPR where CypD-C202 was mutated to a serine (C202S). Infarct size is reduced in CypD-C202S Langendorff perfused hearts compared to wild type (WT). Cardiac mitochondria from CypD-C202S mice also have higher calcium retention capacity compared to WT. Therefore, we hypothesized that oxidation of C202 might target CypD to the PTP. Indeed, isolated cardiac mitochondria subjected to oxidative stress exhibit less binding of CypD-C202S to the proposed PTP component F1F0-ATP-synthase. We previously found C202 to be S-nitrosylated in ischaemic preconditioning. Cysteine residues can also undergo S-acylation, and C202 matched an S-acylation motif. S-acylation of CypD-C202 was assessed using a resin-assisted capture (Acyl-RAC). WT hearts are abundantly S-acylated on CypD C202 under baseline conditions indicating that S-acylation on C202 per se does not lead to PTP opening. CypD C202S knock-in hearts are protected from ischaemia/reperfusion injury suggesting further that lack of CypD S-acylation at C202 is not detrimental (when C is mutated to S) and does not induce PTP opening. However, we find that ischaemia leads to de-acylation of C202 and that calcium overload in isolated mitochondria promotes de-acylation of CypD. Furthermore, a high bolus of calcium in WT cardiac mitochondria displaces CypD from its physiological binding partners and possibly renders it available for interaction with the PTP. CONCLUSIONS: Taken together the data suggest that with ischaemia CypD is de-acylated at C202 allowing the free cysteine residue to undergo oxidation during the first minutes of reperfusion which in turn targets it to the PTP. Published by Oxford University Press on behalf of the European Society of Cardiology 2020. This work is written by US Government employees and is in the public domain in the US.
AIMS: Cyclophilin-D is a well-known regulator of the mitochondrial permeability transition pore (PTP), the main effector of cardiac ischaemia/reperfusion injury. However, the binding of CypD to the PTP is poorly understood. Cysteine 202 (C202) of CypD is highly conserved among species and can undergo redox-sensitive post-translational modifications. We investigated whether C202 regulates the opening of PTP. METHODS AND RESULTS: We developed a knock-in mouse model using CRISPR where CypD-C202 was mutated to a serine (C202S). Infarct size is reduced in CypD-C202S Langendorff perfused hearts compared to wild type (WT). Cardiac mitochondria from CypD-C202S mice also have higher calcium retention capacity compared to WT. Therefore, we hypothesized that oxidation of C202 might target CypD to the PTP. Indeed, isolated cardiac mitochondria subjected to oxidative stress exhibit less binding of CypD-C202S to the proposed PTP component F1F0-ATP-synthase. We previously found C202 to be S-nitrosylated in ischaemic preconditioning. Cysteine residues can also undergo S-acylation, and C202 matched an S-acylation motif. S-acylation of CypD-C202 was assessed using a resin-assisted capture (Acyl-RAC). WT hearts are abundantly S-acylated on CypDC202 under baseline conditions indicating that S-acylation on C202 per se does not lead to PTP opening. CypD C202S knock-in hearts are protected from ischaemia/reperfusion injury suggesting further that lack of CypD S-acylation at C202 is not detrimental (when C is mutated to S) and does not induce PTP opening. However, we find that ischaemia leads to de-acylation of C202 and that calcium overload in isolated mitochondria promotes de-acylation of CypD. Furthermore, a high bolus of calcium in WT cardiac mitochondria displaces CypD from its physiological binding partners and possibly renders it available for interaction with the PTP. CONCLUSIONS: Taken together the data suggest that with ischaemia CypD is de-acylated at C202 allowing the free cysteine residue to undergo oxidation during the first minutes of reperfusion which in turn targets it to the PTP. Published by Oxford University Press on behalf of the European Society of Cardiology 2020. This work is written by US Government employees and is in the public domain in the US.
Authors: T Bochaton; C Crola-Da-Silva; B Pillot; C Villedieu; L Ferreras; M R Alam; H Thibault; M Strina; A Gharib; M Ovize; D Baetz Journal: J Mol Cell Cardiol Date: 2015-04-11 Impact factor: 5.000
Authors: Rimpy Dhingra; Matthew Guberman; Inna Rabinovich-Nikitin; Jonathon Gerstein; Victoria Margulets; Hongying Gang; Nicholas Madden; James Thliveris; Lorrie A Kirshenbaum Journal: Cardiovasc Res Date: 2020-05-01 Impact factor: 10.787
Authors: P W Shaul; E J Smart; L J Robinson; Z German; I S Yuhanna; Y Ying; R G Anderson; T Michel Journal: J Biol Chem Date: 1996-03-15 Impact factor: 5.157
Authors: Boyang Lv; Hanlin Peng; Bingquan Qiu; Lulu Zhang; Mei Ge; Dingfang Bu; Kun Li; Xiaoqi Yu; Jiantong Du; Liu Yang; Chaoshu Tang; Yaqian Huang; Junbao Du; Hongfang Jin Journal: Front Cell Dev Biol Date: 2022-01-18